The congenital adrenal hyperplasia (CAH) therapeutic market is estimated to be valued at USD 392.5 million in 2025 and is expected to reach USD 590.2 million by 2032, growing at a compound annual growth rate (CAGR) of 6.00% from 2025 to 2032. https://kumarkislay.livepositively.com/congenital-adrenal-hyperplasia-cah-therapeutic-market-projected-to-grow-via-gene-editing-therapies/new=1